High throughput sequencing from Roche Diagnostics
Thursday, 26 April, 2007
Roche Diagnostics has launched the second generation of its high throughput sequencing technology, the Genome Sequencer FLX System.
Expanding upon the proven GS 20 System, over 100 million bases can be generated per 7.5-hour instrument run, with reads averaging 200 to 300 bases - ideal for a wide range of applications including amplicon resequencing, transcriptome analysis, gene regulation studies, and comparative genome sequencing.
Australia's largest genomics services company, AGRF Ltd, has placed the first order for a Roche Genome Sequencer FLX System in Australia.
AGRF's acquisition of the Genome Sequencer FLX will complement current Sanger-based sequencing and bioinformatics services to deliver cutting edge sequencing technology to the Australian genomics research and industry sectors.
Please contact Tony Feneziani on 0448 864 095 for details of the services that AGRF offers.
Roche Diagnostics Australia
Tel: 1800 645 619
www.roche-applied-science.com
Alloy implants that naturally dissolve after healing
Australian researchers have been developing biodegradable magnesium-based alloys that more...
Partnership eyes up gene-editing approaches to vision loss
A partnership will build on Australian ophthalmic research into mechanisms that damage nerve...
Irregular blood pressure patterns and dementia-associated brain changes
Hypertension has long been recognised as a risk factor for cognitive decline, yet the impact of...
